Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P28
Within normal range
vs 2Y Ago
-2.2x
Contraction
Streak
6 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.44% |
| Q3 2025 | -5.79% |
| Q2 2025 | -5.18% |
| Q1 2025 | -4.91% |
| Q4 2024 | -4.57% |
| Q3 2024 | -4.16% |
| Q2 2024 | 4.68% |
| Q1 2024 | -3.62% |
| Q4 2023 | 2.89% |
| Q3 2023 | 6.17% |
| Q2 2023 | -3.20% |
| Q1 2023 | -3.01% |
| Q4 2022 | -2.82% |
| Q3 2022 | -2.62% |
| Q2 2022 | -2.49% |
| Q1 2022 | -2.35% |
| Q4 2021 | -2.23% |
| Q3 2021 | -2.06% |
| Q2 2021 | -1.97% |
| Q1 2021 | -1.89% |
| Q4 2020 | -2.19% |
| Q3 2020 | -2.86% |
| Q2 2020 | -66.99% |
| Q1 2020 | 21318.56% |
| Q4 2019 | -99.44% |
| Q3 2019 | -8.82% |
| Q2 2019 | -8.04% |
| Q1 2019 | 0.77% |
| Q4 2018 | 0.78% |
| Q3 2018 | 0.79% |
| Q2 2018 | 0.79% |
| Q1 2018 | 0.80% |
| Q4 2017 | 1477.29% |
| Q3 2017 | -38.54% |
| Q2 2017 | -27.28% |
| Q1 2017 | -20.95% |
| Q4 2016 | -16.90% |
| Q3 2016 | -14.14% |
| Q2 2016 | -12.05% |
| Q1 2016 | -10.49% |